Product Details
Apo-Canagliflozin
Canagliflozin300 mg
Tablet
DIN/PIN/NPN
02564564
Manufacturer
Apotex Inc.
Formulary Listing Date
2026-06-30
Unit Price
0.7515
Amount MOH Pays
0.7515
Coverage Status
General Benefit Chronic-Use Medication Insulin or Oral Hypoglycemic Product
ODB Formulary Therapeutic Classification
Therapeutic Note
Canagliflozin 300 mg Tablet:
Treatment of Type 2 diabetes in patients on maximally tolerated doses of metformin who have:
. Inadequate glycemic control (defined as HbA1c greater than 0.07) and intolerance or contraindication to a sulfonylurea; OR
. Inadequate glycemic control (HbA1c greater than 0.07) and on maximal doses of sulfonylurea and for whom insulin is not an option.
ATC Code
A10BK02
Interchangeable Products
| DIN/ PIN/ NPN | Brand name | Unit Price | Amount MOH pays |
|---|---|---|---|
| 02425491 | Invokana | 3.0060 | 0.7515 |
| 02510375 | Auro-Canagliflozin | 0.7515 | 0.7515 |
| 02543494 | Jamp Canagliflozin | 0.7515 | 0.7515 |
| 02564564 | Apo-Canagliflozin | 0.7515 | 0.7515 |
LU Clinical Criteria
NORequirements